This inventor holds 14 USPTO granted patents and 1 published patent application. Top assignees: Epizon Pharma, Inc., Epizon Phama, Inc.. Active years: 2020-2025.
Company Filing History:
Years Active: 2020-2025
Title: Paul L Darke: Innovator in Medical Treatments
Introduction
Paul L Darke is a notable inventor based in Hingham, MA (US), recognized for his contributions to medical science. He holds a total of 14 patents, focusing on innovative methods and compositions aimed at treating serious health conditions.
Latest Patents
Among his latest patents, Darke has developed methods and compositions for preventing or treating calciphylaxis. This invention provides techniques for slowing the progression of, arresting, and reversing calciphylaxis in subjects with conditions such as diabetes, chronic kidney disease, end-stage renal failure, and COPD. His work also includes methods for preventing or treating tissue calcification, utilizing menaquinone-7 (MK-7) and menaquinol-7 (MKH2-7). Furthermore, he has created methods for reducing symptoms of chronic obstructive pulmonary disorder (COPD) through similar compositions.
Career Highlights
Throughout his career, Paul L Darke has worked with companies such as Epizon Pharma, Inc. His experience in the pharmaceutical industry has significantly contributed to his innovative work in medical treatments.
Collaborations
Darke has collaborated with notable professionals in his field, including James A Tumlin and John M Rudey. These partnerships have likely enhanced his research and development efforts.
Conclusion
Paul L Darke's innovative contributions to medical science, particularly in the treatment of calciphylaxis and tissue calcification, highlight his importance as an inventor. His work continues to impact the lives of individuals suffering from serious health conditions.